Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Silexion Therapeutics Corp (SLXN) had Weighted-Average Shares Outstanding (Basic) of 0.58M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.50M |
|
-- |
|
-- |
|
$2.28M |
|
$-2.28M |
|
$-0.22M |
|
$-2.50M |
|
$-2.50M |
|
$-2.50M |
|
$-2.50M |
|
$-2.50M |
|
$-2.50M |
|
$-2.28M |
|
$-2.28M |
|
|
Weighted-Average Shares Outstanding (Basic) |
0.58M |
0.58M |
|
$-4.32 |
|
$-4.32 |
|
| Balance Sheet Financials | |
$5.24M |
|
$0.03M |
|
$0.56M |
|
$5.80M |
|
$2.15M |
|
$3.19M |
|
$3.53M |
|
$5.68M |
|
$0.12M |
|
$0.12M |
|
$0.12M |
|
0.58M |
|
| Cash Flow Statement Financials | |
$-4.96M |
|
$-0.01M |
|
$7.24M |
|
$1.27M |
|
$3.54M |
|
$2.27M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.44 |
|
-- |
|
-- |
|
0.96 |
|
26.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2085.85% |
|
-2085.84% |
|
-43.18% |
|
-75.62% |
|
$0.21 |
|
$-8.57 |
|
$-8.56 |
|